Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07434661 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR

Study acronym: SAFE-HEART
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
SAFE-HEART is a single-centre, randomized controlled trial comparing the safety and efficiency of Apixaban versus Warfarin in the early period (3 months) after repair or bioprosthetics of the mitral and aortic valve cardiac surgery in patients with atrial fibrillation requiring oral anticoagulation.
Trial Details
NCT Number NCT07434661
Lead Sponsor Meshalkin Research Institute of Pathology of Circulation
Conditions
(from sponsor)		 Valve Disease, Heart, Atrial Fibrillation (AF), Valve Replacement Surgery, Aortic Valve Surgery, Mitral Valve Annuloplasty, Mitral Valve Repair, Mitral Valve Surgery
Related terms Atrial Fibrillation, Heart Valve Diseases
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov